FALCIVAC 180 MG

FALCIVAC 180 is an injectable antimalarial formulation containing Artesunate 180 mg. It is used for the initial treatment of severe malaria, especially infections caused by Plasmodium falciparum. Artesunate is a fast-acting antimalarial that rapidly reduces the parasite burden in the bloodstream and is administered in hospital settings under the supervision of qualified healthcare professionals. Treatment with injectable artesunate should be followed by a complete course of an appropriate oral antimalarial medicine.

Indications / Uses

• Initial treatment of severe malaria caused by Plasmodium falciparum.
• Emergency management of complicated or life-threatening malaria.
• Patients who are unable to take oral antimalarial therapy due to vomiting, unconsciousness, or critical illness.
• Rapid reduction of malaria parasite load before switching to oral antimalarial treatment.
• Use in adults and pediatric patients as directed by a qualified healthcare professional.